Global Viscosupplementation Market to Surpass US$ 4,738.8 Million by 2027 - Coherent Market Insights

News provided by

Jan 27, 2020, 09:58 ET

SEATTLE, Jan. 27, 2020 /PRNewswire/ -- According to Coherent Market Insights, the global viscosupplementation market is estimated to be valued at US$ 2,524.8 million in 2019, and is expected to exhibit a CAGR of 8.2% over the forecast period (2019-2027).

Key Trends and Analysis of the Global Viscosupplementation Market:

Increasing product launches and regulatory approvals by manufacturers is expected to propel the global viscosupplementation market growth over the forecast period. For instance, in January 2017, Anika Therapeutics, Inc. received CE (European Conformity) Mark approval for its product, ORTHOVISC-T (sodium hyaluronate for peritendinous injection). It is a viscosupplement injectable designed to relieve pain and restore functions to tendons damaged by chronic tennis elbow.

Request for Sample PDF @ https://www.coherentmarketinsights.com/insight/request-sample/197

Moreover, in March 2019, Seikagaku Corporation, a Japan-based pharmaceutical company, launched HyLink, an intra-articular single-injection viscosupplement indicated for treatment of knee osteoarthritis, in Italy.

Awareness created by organizations and institutions through campaigns is expected to drive the global viscosupplementation market growth over the forecast period. For instance, in 2018, on the occasion of Arthritis Awareness Month, the Arthritis Foundation organized a new campaign called the 'Let's Get a Grip on Arthritis' with the goal of eradicated it once and for all.

Moreover, Arthritis and Rheumatism International (ARI) organization has established World Arthritis Day (WAD) in 1996, after that Ministry of Health and Family Welfare (MoHFW) every year celebrate 12^th October as a World Arthritis Day to raise awareness among people.

Restraint of the global viscosupplementation market

The major factor restraining the market growth is the high cost of viscosupplement injections, which also results in an increased treatment cost of osteoarthritis.

Key Market Takeaways:

The Viscosupplementation market is expected to exhibit a CAGR of 8.2% over the forecast period (2019-2027). This growth is attributed to frequent product launches, approvals of viscosupplementation products, and increasing demand for viscosupplementation therapy
Key players in the market are involved in strategic partnerships and collaborations, which is expected to facilitate growth of global viscosupplementation market. For instance, in May 2016, Anika Therapeutics, Inc. has formed commercialization partnership with Pendopharm, to sell CINGAL, in Canada

Key players operating in the global viscosupplementation market include

Anika Therapeutics Inc., Seikagaku Corporation, Ferring Pharmaceuticals, Bioventus, Fidia Farmaceutici S.P.A., Mylan N.V., Sanofi S.A., OrthogenRx, Teva Pharmaceutical Industries Ltd, and Johnson & Johnson.

Buy this Report (Single User License) @ https://www.coherentmarketinsights.com/insight/buy-now/197

Market Segmentation:

Global Viscosupplementation Market, By Treatment:

Single Injection Treatment Cycle
Three Injection Treatment Cycle
Five Injection Treatment Cycle

Global Viscosupplementation Market, By Application:

Knee Osteoarthritis
Hip Osteoarthritis
Others

Global Viscosupplementation Market, By Region:

North America

U.S.
Canada

Europe

U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe

Latin America

Brazil
Mexico
Argentina
Rest of Latin America

Asia Pacific

China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific

Middle East

GCC
Israel
Rest of Middle East

Africa

Central Africa
South Africa
North Africa

Insights on similar Topics:

Osteoarthritis Treatment Market

Osteoarthritis can be treated by several treatments, which include exercise for reducing joint pain, pain medications, and support groups. Pain medication includes drugs such as paracetamol, naproxen, and ibuprofen. Joint replacement is opted in cases of severe pain that results in interference with the regular activities.

Factor VIII Deficiency Treatment Market

Factor VIII deficiency treatment market is expected to witness significant growth over the forecast period, owing to increasing number of hemophilic cases. For instance, according to the World Federation of Hemophilia 2017 statistics, in India, around 18,353 people suffered from hemophilia and 15,218 people were diagnosed with hemophilia A in 2016, out of which around 83.0% had factor VIII deficiency.

Compounding Pharmacies Market

Compounding pharmacies is a pharmacy operated by registered pharmacist or physician or person under the guidance of registered pharmacist. Compounding pharmacy is slightly differ from traditional pharmacy however the main role of compounding pharmacy is to develop drugs which are prescribed by physician according to patient specific requirement.

Contact Us:

Mr. Raj Shah
Coherent Market Insights
1001 4th Ave.
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

SOURCE Coherent Market Insights